反応式
[CH3:1][O:2][C:3]1[CH:4]=[C:5]2[CH2:14][CH:13]([CH2:15][CH:16]3[CH2:21][CH2:20][N:19](CC4C=CC=CC=4)[CH2:18][CH2:17]3)[C:11](=[O:12])[C:6]2=[CH:7][C:8]=1[O:9][CH3:10].Cl.S(C1C=CC(C)=CC=1)(O)(=O)=O.COC1C=C2C(=CC=1OC)C(=O)C(=CC1C=CN=CC=1)C2>[Pd].O>[CH3:1][O:2][C:3]1[CH:4]=[C:5]2[C:6](=[CH:7][C:8]=1[O:9][CH3:10])[C:11](=[O:12])[CH:13]([CH2:15][CH:16]1[CH2:21][CH2:20][NH:19][CH2:18][CH2:17]1)[CH2:14]2参加物
5
実験手順
US Patent Application published under the No. 2007/0135644A1 discloses the preparation of donepezil hydrochloride by reducing 5,6-dimethoxy-2-[1-(4-pyridinyl)methylidene]-1-indanone tosylate with 10% Pd/C catalyst in demi-water at 70-95° C., at 10 bar for 8 hours. The mixture is extracted three times with 1-butanol to afford a residue which is purified with methyl-tert-butyl ether to obtain 5,6-dimethoxy-2-(4-piperidinylmethyl)-1-indanone, followed by condensation with benzyl chloride in toluene for 8 hours at 145° C. to yield donepezil which is further converted to donepezil hydrochloride.
後処理
- customat 70-95° C.
- extractionThe mixture is extracted three times with 1-butanol
- customto afford a residue which
- customis purified with methyl-tert-butyl ether
出典と根拠
- ORDレコード
- ord-eba17d7fd1b64cb99f825e1904e1379e
- 出典データセット
- uspto-grants-2015_03
- 特許番号
- US08987458B2
関連ノート
読み込み中…